MAX
Simple chart
Extended chart
Main settings
| 10 year return | 0 |
| 3 year return | -1.82 |
| 5 year return | 0 |
| Annual return | 46.46 |
| Asset size | Large-Cap |
| Asset type | Equity |
| Average P/BV | 3.66 |
| Average P/E | 20.39 |
| Average P/S | 4.82 |
| Commission | 0.19 |
| Country | USA |
| Currency | usd |
| Div. yield | 0.86 |
| Focus | Health Care |
| Foundation date | 2021-06-09 |
| ISIN code | US46138G5999 |
| ISO country | US |
| Index | NASDAQ / Biotechnology |
| Number of companies | 207 |
| Owner | Invesco |
| Region | North America |
| Region | U.S. |
| Strategy | Exchange-specific |
| Website | link |
| segment | Equity: U.S. Pharma, Biotech & Life Sciences |
| Change per day | -2.16% 29.54 $ |
| Change per week | +1.85% 28.377 $ |
| Change per month | +3.3% 27.98 $ |
| Change per 3 month | +9.04% 26.507 $ |
| Change per half year | +21.39% 23.81 $ |
| Change per year | +40.99% 20.5 $ |
| Change per year to date | +1.97% 28.346 $ |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Similar ETF
Other ETFs from the Management Company
| Title | Class | Category | Commission | Annual return |
| Equity | 0.2 | 40.39 | ||
| Equity | 0.2 | 19.27 | ||
| Equity | 0.02 | 29.09 | ||
| Equity | 0.15 | 39.67 | ||
| Equity | 0.15 | 31.41 | ||
| Equity | 0.15 | 20.67 | ||
| Bond | 0.65 | 2.63 | ||
| Equity | 0.39 | 26.04 | ||
| Equity | 0.29 | 21.9 | ||
| Commodity | 0.59 | 4.6 | ||
| Equity | 0.2 | 37.57 | ||
| Bond | 0.1 | 0.0242 | ||
| Equity | 0.4 | 47.81 | ||
| Bond | 0.1 | -0.14 | ||
| Equity | 0.58 | 51.66 | ||
| Bond | 0.1 | 0.71 | ||
| Equity | 0.39 | 23.86 | ||
| Equity | 0.3 | 1.44 | ||
| Bond | 0.28 | 4.81 | ||
| Equity | 0.34 | 29.96 | ||
| Equity | 0.39 | 33.94 | ||
| Equity | 0.6 | 13.63 | ||
| Equity | 0.35 | 20.74 | ||
| Bond | 0.23 | 0.64 | ||
| Bond | 0.1 | 1.15 | ||
| Commodity | 0.85 | 6.28 | ||
| Equity | 0.45 | 27.21 | ||
| Bond | 0.08 | 0.27 | ||
| Multi-Asset | 0.5 | 2.37 | ||
| Bond | 0.1 | 1.77 |
Description Invesco Nasdaq Biotechnology ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
Based on sources: porti.ru
